Intravenous diclofenac holds promise against severe pain following oral surgery
Links shared publicly online about this topic.
- 189total visits
Intravenous diclofenac holds promise against severe pain following oral surgery
An essential aspect of oral surgery is controlling the patient's pain following a procedure. The goal is to relieve pain and promote a rapid recovery, without opioid side effects. An initial study shows that Dyloject, a new intravenous form of the drug diclofenac, has promise for achieving these goals.
View full resource at news-medical.net
Tags: Pain, Osteoarthritis Medication, Rheumatoid Arthritis Medication, Oral Surgery, NSAIDs, Voltaren, Cataflam, Surgery
Most Recently Shared on June 27, 2011 at 5:43 am By:
Intravenous diclofenac holds promise against severe pain following oral surgery: An essential aspect of oral sur... http://bit.ly/ixvDYb
Advertisement
